Range Low Price High Price Comment
30 days $21.49 $24.07 Wednesday, 27th Mar 2024 EXEL stock ended at $23.86. This is 1.06% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 1.01% from a day low at $23.66 to a day high of $23.90.
90 days $19.21 $24.34
52 weeks $18.08 $24.34

Historical Exelixis prices

Date Open High Low Close Volume
2024-03-27 $23.78 $23.90 $23.66 $23.86 1 544 702
2024-03-26 $23.70 $23.80 $23.58 $23.61 1 878 965
2024-03-25 $23.75 $23.93 $23.65 $23.70 2 009 671
2024-03-22 $24.02 $24.02 $23.77 $23.78 1 838 094
2024-03-21 $23.82 $24.07 $23.56 $23.92 2 644 592
2024-03-20 $23.41 $23.73 $23.28 $23.71 2 205 806
2024-03-19 $23.19 $23.51 $23.18 $23.47 2 326 922
2024-03-18 $23.14 $23.42 $23.07 $23.17 2 292 087
2024-03-15 $22.62 $23.02 $22.55 $22.98 4 563 606
2024-03-14 $23.02 $23.10 $22.40 $22.61 2 429 942
2024-03-13 $22.77 $23.19 $22.77 $23.07 2 588 083
2024-03-12 $22.42 $22.71 $22.32 $22.69 1 979 758
2024-03-11 $22.34 $22.59 $22.24 $22.46 2 116 428
2024-03-08 $22.12 $22.38 $22.05 $22.21 1 320 275
2024-03-07 $22.49 $22.51 $22.08 $22.09 1 798 588
2024-03-06 $22.33 $22.54 $22.31 $22.38 1 844 907
2024-03-05 $22.57 $22.81 $22.24 $22.26 2 415 755
2024-03-04 $22.48 $22.66 $22.23 $22.55 2 205 848
2024-03-01 $22.01 $22.63 $22.01 $22.24 3 368 230
2024-02-29 $22.08 $22.25 $21.88 $21.90 3 141 473
2024-02-28 $21.64 $22.04 $21.49 $21.91 2 351 030
2024-02-27 $21.97 $22.03 $21.61 $21.71 2 483 700
2024-02-26 $21.49 $21.99 $21.49 $21.96 2 173 763
2024-02-23 $21.29 $21.78 $21.15 $21.53 2 637 810
2024-02-22 $20.72 $20.88 $20.49 $20.71 1 782 677
Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT